Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma - Straka, Christian; Schaefer-Eckart, Kerstin; Hertenstein, Bernd; Bassermann, Florian; Salwender, Hans; Langer, Christian; Kroenke, Jan; Kull, Miriam; Schilling, Georgia; Schieferdecker, Aneta; Engelhardt, Monika; Knop, Stefan; et al. (BLOOD, 2022)
CRIS-Team WoS Importer:2023-03-10